Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Breast Cancer Research and Treatment aims to fill this need.

Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All man uscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.

Why publish with us

  • For more than 35 years, our journal has been a reliable resource for a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists interested in breast cancer.
  • With 800K+ article downloads each year, the journal provides a high visibility platform for your research.
  • We create a "market place" for breast cancer topics, with international editorial board from world-class centres determining the best articles from authors worldwide.
  • We provide high levels of author satisfaction, with 93% of our published authors reporting that they would definitely or probably publish with us again.

Journal information

Editor-in-Chief
  • William J. Gradishar
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.624 (2021)
Impact factor
4.845 (2021)
Five year impact factor
24 days
Submission to first decision (Median)
1,203,482 (2021)
Downloads

Latest articles

Journal updates

View all updates

About this journal

Electronic ISSN
1573-7217
Print ISSN
0167-6806
Abstracted and indexed in
  1. AGRICOLA
  2. ANVUR
  3. BFI List
  4. BIOSIS
  5. Baidu
  6. Biological Abstracts
  7. CAB Abstracts
  8. CLOCKSS
  9. CNKI
  10. CNPIEC
  11. Chemical Abstracts Service (CAS)
  12. Current Contents/ Life Sciences
  13. Current Contents/Clinical Medicine
  14. Dimensions
  15. EBSCO Biomedical Reference Collection
  16. EBSCO Discovery Service
  17. EBSCO Gender Studies Database
  18. EMBASE
  19. Gale
  20. Google Scholar
  21. INIS Atomindex
  22. Japanese Science and Technology Agency (JST)
  23. Journal Citation Reports/Science Edition
  24. Medline
  25. Naver
  26. OCLC WorldCat Discovery Service
  27. Pathway Studio
  28. Portico
  29. ProQuest-ExLibris Primo
  30. ProQuest-ExLibris Summon
  31. Reaxys
  32. SCImago
  33. SCOPUS
  34. Science Citation Index
  35. Science Citation Index Expanded (SCIE)
  36. Semantic Scholar
  37. TD Net Discovery Service
  38. UGC-CARE List (India)
  39. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature